Our Approach

Our platform technology unlocks the pro-resolution biology of endogenous fatty acids to create novel, non-immunosuppressive therapies for treatment of IBD and polyposis.

Pro-Resolution Lipid Biology

Leveraging the robust inflammation-resolving properties of endogenous bioactive lipids to treat GI diseases

HEALER™ Platform

Chemically transforming endogenous bioactive lipids into small molecules with superior pharmaceutical properties

Intellectual Property

Long-term composition of matter patent protection on new molecular entities via the HEALER platform

"We are committed to creating innovative products that improve the lives of patients suffering from GI diseases."